Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that understanding nail anatomy is key for diagnosing nail diseases, early signs of nail melanoma may allow for less aggressive treatment, and specific genetic mutations are important in thyroid cancer prognosis and treatment.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Dermoscopy is useful for diagnosing various skin, hair, and nail disorders and can reduce the need for biopsies.

Heavy metals like arsenic, cadmium, and lead can increase cancer risk and worsen outcomes.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Hair elemental analysis could be useful for health and exposure assessment but requires more standardization and research.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Cancer drugs often cause temporary hair, skin, nail, and mouth issues.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

Some skin, hair, and nail supplements can be toxic, interact with medications, affect lab tests, and may increase cancer risk.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

The document concludes that while white skin, nail, and mucosa diseases increase skin cancer risk, they are generally harmless, especially compared to darker pigmentation conditions.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Alopecia can be linked to autoimmune issues, vitiligo, nail problems, and sometimes cancer treatments.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

A man with Cronkhite-Canada syndrome improved significantly with immunosuppressive therapy.

Older adults commonly experience wrinkles, itchy skin, psoriasis, fungal infections, skin growths, grey hair, hair loss, and nail ridging, but no skin cancer was found in this group.

First Korean case of Cronkhite-Canada syndrome with colon cancer and serrated adenoma.